evlampiyacyxybyw.blogspot.com
Genzyme (NASDAQ: GENZ) found a viruse strain and stopped production of two drugws atthe Allston, Mass., facility. The strain, Vesiviru 2117, apparently does not causes human infection but interrupts the growth of cellz that are used tomake drugs. Aldurazyme a treatment for MPS I, a rare and fatal disease caused by an enzymedeficiency — was last fillefd at the Genzyme facilituy in September 2008, according to BioMarin BMRN). The company has about 10 months of vialed inventoryyon hand, it said, and uses a secone fill finish supplier. A thirsd supplier is expected to be qualified late rthis year, BioMarin BioMarin makes the bulk material used in Aldurazymr at its Novato facility.
The Food and Drug Administrationm hadinspected Genzyme’s plant in September and Octobedr and reportedly was concerned about control to protect against contamination.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment